0.200
0.00 (-2.44%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (MY) | Mixed | - |
| Drug Manufacturers - Specialty & Generic (Global) | Bullish | Bullish | |
| Stock | PLABS | - | - |
|
Peterlabs Holdings Bhd is a Malaysia based company engaged in manufacturing, distribution, and trading of animal health and nutrition products. It also provides solutions like farm management, technical advisory services, raw material analysis and feed formulation. The operating segments of the group are Manufacturing which relates to manufacturing of animal health and nutrition products, and Trading which relates to trading and distribution of animal health and nutrition products. It offers products like animal feed additives, veterinary pharmaceuticals, injectable products, multi-nutrient and supplement, topical dressings, cleansing agents, and other related products. The company operates in Malaysia and internationally, and generates key revenue from the Trading segment. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Value |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| MR BU YAW SENG | 0.198 | - | 489,000 | 97,365 |
| Aggregate Net Quantity | 489,000 | |||
| Aggregate Net Value ($) | 97,365 | |||
| Aggregate Avg. Buy ($) | 0.198 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| MR BU YAW SENG | Substantial Shareholder | 13 May 2024 | Acquired (+) | 201,000 | 0.205 | 41,205 |
| MR BU YAW SENG | Substantial Shareholder | 10 May 2024 | Acquired (+) | 88,000 | 0.195 | 17,160 |
| MR BU YAW SENG | Substantial Shareholder | 09 May 2024 | Acquired (+) | 200,000 | 0.195 | 39,000 |
| Date | Type | Details |
|---|---|---|
| 14 May 2024 | Announcement | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MR BU YAW SENG |
| 10 May 2024 | Announcement | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MR BU YAW SENG |
| 30 Apr 2024 | Announcement | Annual Report & CG Report - 2023 |
| 29 Apr 2024 | Announcement | General Meetings: Notice of Meeting |
| 16 Apr 2024 | Announcement | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MR BU YAW SENG |
| 14 Mar 2024 | Announcement | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MR BU YAW SENG |
| 08 Mar 2024 | Announcement | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MR BU YAW SENG |
| 07 Mar 2024 | Announcement | PLABS - Notice of Book Closure |
| 06 Mar 2024 | Announcement | Interim Dividend |
| 29 Feb 2024 | Announcement | Quarterly rpt on consolidated results for the financial period ended 31/12/2023 |
| TTM Dividend Yield | 2.00% |
| 5Y Average Dividend Yield | 3.11% |
| Expected Next Dividend Payment | Mar 2025 |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 21 Mar 2024 | 06 Mar 2024 | 29 Mar 2024 | 0.004 Cash |
| 14 Jul 2022 | 20 Jun 2022 | 22 Jul 2022 | 0.006 Cash |
| 01 Oct 2020 | 17 Sep 2020 | 09 Oct 2020 | 0.01 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2024 | 0.004 | 1 | 2.00 |
| 2022 | 0.006 | 1 | 3.08 |
| 2020 | 0.010 | 1 | 4.26 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |